These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 39069612)

  • 1. The significant role of amino acid metabolic reprogramming in cancer.
    Liu X; Ren B; Ren J; Gu M; You L; Zhao Y
    Cell Commun Signal; 2024 Jul; 22(1):380. PubMed ID: 39069612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.
    Liu Y; Zhao Y; Song H; Li Y; Liu Z; Ye Z; Zhao J; Wu Y; Tang J; Yao M
    Cancer Lett; 2024 Aug; 597():217076. PubMed ID: 38906524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
    Li Z; Sun C; Qin Z
    Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
    Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
    Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution.
    Zhang F; Ma Y; Li D; Wei J; Chen K; Zhang E; Liu G; Chu X; Liu X; Liu W; Tian X; Yang Y
    J Hematol Oncol; 2024 Sep; 17(1):80. PubMed ID: 39223656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy.
    Yang L; Chu Z; Liu M; Zou Q; Li J; Liu Q; Wang Y; Wang T; Xiang J; Wang B
    J Hematol Oncol; 2023 Jun; 16(1):59. PubMed ID: 37277776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications.
    Taneja N; Chauhan A; Kulshreshtha R; Singh S
    Life Sci; 2024 Sep; 352():122890. PubMed ID: 38971364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming of the tumour microenvironment.
    Xing Y; Zhao S; Zhou BP; Mi J
    FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy.
    Lim SA
    BMB Rep; 2024 Sep; 57(9):388-399. PubMed ID: 38919017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acids in cancer.
    Lieu EL; Nguyen T; Rhyne S; Kim J
    Exp Mol Med; 2020 Jan; 52(1):15-30. PubMed ID: 31980738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments.
    Chen Z; Yam JWP; Mao X
    Proteomics; 2024 Jun; 24(11):e2300021. PubMed ID: 38171844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
    Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
    Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
    Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
    Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling.
    Yang J; Liu F; Wang Y; Qu L; Lin A
    Cancer Lett; 2022 Sep; 543():215798. PubMed ID: 35738332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment.
    Adhikari S; Guha D; Mohan C; Mukherjee S; Tyler JK; Das C
    Subcell Biochem; 2022; 100():3-65. PubMed ID: 36301490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide metabolism in the regulation of tumor microenvironment and immune cell function.
    Madsen HB; Peeters MJ; Straten PT; Desler C
    Curr Opin Biotechnol; 2023 Dec; 84():103008. PubMed ID: 37863018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity.
    Zheng Y; Yao Y; Ge T; Ge S; Jia R; Song X; Zhuang A
    J Exp Clin Cancer Res; 2023 Nov; 42(1):291. PubMed ID: 37924140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA Modifications in Cancer Metabolism and Tumor Microenvironment.
    Qing Y; Wu D; Deng X; Chen J; Su R
    Cancer Treat Res; 2023; 190():3-24. PubMed ID: 38112997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.